Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria

    July 2016 in “ Journal of Investigative Dermatology ”
    Hiroshi Mitsui, Felix Kiecker, Avner Shemer, Maria Vittoria Cannizzaro, Claire Q. Wang, Nicholas Gulati, Hanako Ohmatsu, Kejal R. Shah, Patricia Gilleaudeau, Mary Sullivan‐Whalen, Inna Cueto, N. Scott McNutt, Mayte Suárez‐Fariñas, James G. Krueger
    Studysummary This study identified molecular differences between dysplastic nevi and common melanocytic nevi, including altered keratinocyte differentiation, increased hair follicle-related molecule expression, and distinct immune microenvironment characteristics in dysplastic nevi.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study differentiated dysplastic nevi (DNs) from common melanocytic nevi (CMNs) using cellular and molecular criteria, involving 5 CMNs, 7 DNs, and 6 normal skin samples. Researchers identified 111 differentially expressed probesets, with DNs showing increased expression of hair follicle-related genes and distinct immune microenvironments. Key findings included upregulation of genes like KRT25 and TCHH, and immune-related cytokines such as IL12B and IFNγ. DUSP3 was highlighted as a key gene distinguishing DNs from CMNs. The study concluded that DNs are distinct entities with unique gene expression profiles, suggesting they are not merely subtypes of CMNs. Further research with larger sample sizes was recommended.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results